Cyclacel Pharmaceuticals, Inc. (CYCC)
$5.16-2.46%Close
SELLRECOVERY · day 1
Key stats
- Market cap
- $9M
- Avg volume
- 1.8M
- Beta
- 0.16
- P/E (TTM)
- -3.08
- 1W
- +13.66%
- 1M
- -23.78%
- YTD
- -31.66%
- vs SPY 1W
- +14.85%
- vs SPY 1M
- -27.10%
- vs SPY YTD
- -43.41%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- GELSSELLGelteq Limited Ordinary SharesCRISISQ -13$0.53-5.36%
- EBSSELLEmergent BioSolutions Inc.CRISISQ 12$5.18+1.97%
- SNDXSELLSyndax Pharmaceuticals, Inc.RECOVERYQ 18$19.57-0.41%
- ELUTBUYElutia Inc.RECOVERYQ -20$0.95+0.00%
- SILOSELLSilo Pharma, Inc.CRISISQ -2$2.58-2.64%
- VTGNBUYVistaGen Therapeutics, Inc.CRISISQ -7$0.24+0.00%
- HOWLBUYWerewolf Therapeutics, Inc.RECOVERYQ -14$0.88+1.15%
- CSBRSELLChampions Oncology, Inc.CRISISQ 12$4.97+0.20%
- RNABUYAtrium Therapeutics, Inc.RECOVERYQ -23$13.62+3.18%
- ENTABUYEnanta Pharmaceuticals, Inc.RECOVERYQ 13$14.10+4.68%
- EVGNBUYEvogene Ltd.CRISISQ 1$0.56+0.00%
- IRDBUYOpus Genetics, Inc.RECOVERYQ -0$4.03-0.49%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
Loading headlines…